Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy
- PMID: 15205352
- DOI: 10.1158/0008-5472.CAN-04-0138
Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy
Abstract
Dendritic cells (DCs) are potent stimulators of immunity, and DCs pulsed with tumor antigen ex vivo have applications in tumor immunotherapy. However, DCs are a small population of cells, and their isolation and pulsing with antigen can be impractical. Here we show that a crude preparation of plasma membrane vesicles (PMV) from the highly metastatic murine melanoma (B16-OVA) and a surrogate tumor antigen (OVA) can be targeted directly to DCs in vivo to elicit functional effects. A novel metal-chelating lipid, 3(nitrilotriacetic acid)-ditetradecylamine, was incorporated into B16-OVA-derived PMV, allowing recombinant hexahistidine-tagged forms of single chain antibody fragments to the DC surface molecules CD11c and DEC-205, to be conveniently "engrafted" onto the vesicle surface by metal-chelating linkage. The modified PMV, or similarly engrafted synthetic stealth liposomes containing OVA or OVA peptide antigen, were found to target DCs in vitro and in vivo, in experiments using flow cytometry and fluorescence confocal microscopy. When used as vaccines in syngeneic mice, the preparations stimulated strong B16-OVA-specific CTL responses in splenic T cells and a marked protection against tumor growth. Protection was dependent on the simultaneous delivery of both antigen and a DC maturation or "danger signal" signal (IFN-gamma or lipopolysaccharide). Administration of the DC-targeting vaccine to mice challenged with B16-OVA cells induced a dramatic immunotherapeutic effect and prolonged disease-free survival. The results show that the targeting of antigen to DCs in this way is highly effective at inducing immunity and protection against the tumor, with protection being at least partially dependent on the eosinophil chemokine eotaxin.
Similar articles
-
Antigen-containing liposomes engrafted with flagellin-related peptides are effective vaccines that can induce potent antitumor immunity and immunotherapeutic effect.J Immunol. 2010 Aug 1;185(3):1744-54. doi: 10.4049/jimmunol.1000027. Epub 2010 Jul 7. J Immunol. 2010. PMID: 20610649
-
Dendritic cells that endocytosed antigen-containing IgG-liposomes elicit effective antitumor immunity.J Immunother. 2006 Mar-Apr;29(2):165-74. doi: 10.1097/01.cji.0000190169.61416.f5. J Immunother. 2006. PMID: 16531817
-
Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.Oncol Rep. 2006 Dec;16(6):1317-24. Oncol Rep. 2006. PMID: 17089056
-
Liposomal vaccines--targeting the delivery of antigen.Methods. 2006 Sep;40(1):39-52. doi: 10.1016/j.ymeth.2006.05.027. Methods. 2006. PMID: 16997712 Review.
-
Targeting dendritic cells with antigen-containing liposomes: antitumour immunity.Expert Opin Biol Ther. 2004 Nov;4(11):1735-47. doi: 10.1517/14712598.4.11.1735. Expert Opin Biol Ther. 2004. PMID: 15500402 Review.
Cited by
-
Tailoring biomaterials for vaccine delivery.J Nanobiotechnology. 2024 Aug 12;22(1):480. doi: 10.1186/s12951-024-02758-0. J Nanobiotechnology. 2024. PMID: 39135073 Free PMC article. Review.
-
Targeting lymph nodes for enhanced cancer vaccination: From nanotechnology to tissue engineering.Mater Today Bio. 2024 Apr 26;26:101068. doi: 10.1016/j.mtbio.2024.101068. eCollection 2024 Jun. Mater Today Bio. 2024. PMID: 38711936 Free PMC article. Review.
-
Revolutionizing lymph node metastasis imaging: the role of drug delivery systems and future perspectives.J Nanobiotechnology. 2024 Mar 29;22(1):135. doi: 10.1186/s12951-024-02408-5. J Nanobiotechnology. 2024. PMID: 38553735 Free PMC article. Review.
-
Protein-Decorated Microbubbles for Ultrasound-Mediated Cell Surface Manipulation.ACS Appl Bio Mater. 2023 Dec 18;6(12):5746-5758. doi: 10.1021/acsabm.3c00861. Epub 2023 Dec 4. ACS Appl Bio Mater. 2023. PMID: 38048163 Free PMC article.
-
Vaccine approaches for antigen capture by liposomes.Expert Rev Vaccines. 2023 Jan-Dec;22(1):1022-1040. doi: 10.1080/14760584.2023.2274479. Epub 2023 Nov 6. Expert Rev Vaccines. 2023. PMID: 37878481 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials